An Expert Panel Delphi Consensus Statement on Appropriate Patient Selection and Management of Adverse Events in Patients Receiving Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.